Personalis, Inc. announced a collaboration with UC San Francisco (UCSF) that will deploy a personalized liquid biopsy-based research use only assay for a study of patients with colorectal cancer.
[Personalis, Inc.]
Home Newsletters Cancer Stem Cell News Personalis and UCSF to Study Clinical Utility of ctDNA for Treatment Response...
